JP2009500397A - エピナスチンを含む眼科用経皮吸収型製剤 - Google Patents

エピナスチンを含む眼科用経皮吸収型製剤 Download PDF

Info

Publication number
JP2009500397A
JP2009500397A JP2008520118A JP2008520118A JP2009500397A JP 2009500397 A JP2009500397 A JP 2009500397A JP 2008520118 A JP2008520118 A JP 2008520118A JP 2008520118 A JP2008520118 A JP 2008520118A JP 2009500397 A JP2009500397 A JP 2009500397A
Authority
JP
Japan
Prior art keywords
epinastine
pharmaceutically acceptable
acceptable salt
subject
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2008520118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009500397A5 (enExample
Inventor
明治 礒脇
朋子 中嶋
聡 大鳥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of JP2009500397A publication Critical patent/JP2009500397A/ja
Publication of JP2009500397A5 publication Critical patent/JP2009500397A5/ja
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2008520118A 2005-07-08 2006-07-07 エピナスチンを含む眼科用経皮吸収型製剤 Abandoned JP2009500397A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69736905P 2005-07-08 2005-07-08
PCT/JP2006/314005 WO2007007851A1 (en) 2005-07-08 2006-07-07 Percutaneously absorptive ophthalmic preparation comprising epinastine

Publications (2)

Publication Number Publication Date
JP2009500397A true JP2009500397A (ja) 2009-01-08
JP2009500397A5 JP2009500397A5 (enExample) 2009-08-20

Family

ID=37016261

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008520118A Abandoned JP2009500397A (ja) 2005-07-08 2006-07-07 エピナスチンを含む眼科用経皮吸収型製剤

Country Status (6)

Country Link
US (1) US20090143359A1 (enExample)
EP (1) EP1901724A1 (enExample)
JP (1) JP2009500397A (enExample)
KR (1) KR20080034916A (enExample)
CN (1) CN101217948A (enExample)
WO (1) WO2007007851A1 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010502564A (ja) * 2006-08-28 2010-01-28 千寿製薬株式会社 眼科用経皮吸収型製剤
JP2011190204A (ja) * 2010-03-12 2011-09-29 Nitto Denko Corp セレギリン含有貼付製剤
JP2020172486A (ja) * 2019-04-10 2020-10-22 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
WO2022138842A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
WO2022138826A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩を含有する塗布投与用医薬組成物
JP2022136242A (ja) * 2020-10-08 2022-09-15 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
WO2025205960A1 (ja) * 2024-03-27 2025-10-02 参天製薬株式会社 エピナスチン又はその塩を含有する経皮投与用医薬組成物と抗アレルギー薬との組み合わせ

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2752008T3 (es) * 2009-10-30 2020-04-02 Intratus Inc Métodos y composiciones para la liberación sostenida de fármacos
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
CN116669705A (zh) * 2020-12-24 2023-08-29 参天制药株式会社 含有依匹斯汀或其盐的涂布施予用医药组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
RU2125427C1 (ru) * 1998-05-27 1999-01-27 Миронова Эмилия Михайловна Средство для лечения глазных заболеваний - оковидит
TWI233810B (en) * 1999-02-19 2005-06-11 Hisamitsu Pharmaceutical Co A paster sheet
WO2001026648A1 (en) * 1999-10-13 2001-04-19 Senju Pharmaceutical Co., Ltd. Ophthalmic adhesive preparations for percutaneous absorption
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10060852A1 (de) * 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
US6659985B2 (en) * 2002-01-30 2003-12-09 Southern College Of Optometry Method to use transdermal administration of androgens to the adnexa of the eye
EP1591110B1 (en) * 2003-01-22 2015-03-18 Senju Pharmaceutical Co., Ltd. Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
JP5315051B2 (ja) * 2005-07-08 2013-10-16 千寿製薬株式会社 オロパタジンを含む眼科用経皮吸収型製剤

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010502564A (ja) * 2006-08-28 2010-01-28 千寿製薬株式会社 眼科用経皮吸収型製剤
JP2011190204A (ja) * 2010-03-12 2011-09-29 Nitto Denko Corp セレギリン含有貼付製剤
JP2020172486A (ja) * 2019-04-10 2020-10-22 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP7599838B2 (ja) 2019-04-10 2024-12-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP2022136242A (ja) * 2020-10-08 2022-09-15 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
JP7628098B2 (ja) 2020-10-08 2025-02-07 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
WO2022138842A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
WO2022138826A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩を含有する塗布投与用医薬組成物
JP7124248B1 (ja) * 2020-12-24 2022-08-23 参天製薬株式会社 エピナスチン又はその塩を含有する塗布投与用医薬組成物
WO2025205960A1 (ja) * 2024-03-27 2025-10-02 参天製薬株式会社 エピナスチン又はその塩を含有する経皮投与用医薬組成物と抗アレルギー薬との組み合わせ

Also Published As

Publication number Publication date
US20090143359A1 (en) 2009-06-04
KR20080034916A (ko) 2008-04-22
EP1901724A1 (en) 2008-03-26
CN101217948A (zh) 2008-07-09
WO2007007851A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
EP2493474B1 (en) Methods and compositions for sustained delivery of drugs
JP5020061B2 (ja) 経皮吸収型製剤
JP4629578B2 (ja) 眼疾患治療用経皮吸収型製剤
CA2360300C (en) A transdermal composition of an antivomiting agent and a preparation containing the same
EP2056809A1 (en) Ophthalmic percutaneous absorption type preparation
JP5315051B2 (ja) オロパタジンを含む眼科用経皮吸収型製剤
JP2009500397A (ja) エピナスチンを含む眼科用経皮吸収型製剤
JP4308255B2 (ja) ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤
CN107753419B (zh) 他克莫司外用制剂
US20090005319A1 (en) Topical compositions for delaying ejaculation and methods of using the same
TW201717920A (zh) 經皮吸收型製劑
JP2004099486A (ja) フリーラジカル性疾患用外用剤
KR20070018755A (ko) 무스카린 수용체 작동약을 함유한 안과용 경피흡수형 제제
WO2007013661A1 (ja) 眼科用経皮吸収型製剤
KR20010014479A (ko) 경피투여용 항구토제 조성물 및 이를 포함하는 제제
JP2021102573A (ja) クエン酸フェンタニル含有経皮吸収製剤
HK1175119A (en) Methods and compositions for sustained delivery of drugs

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090703

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090703

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20110324